Clinical Trials Logo

Hemostasis clinical trials

View clinical trials related to Hemostasis.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06199414 Not yet recruiting - Atrial Fibrillation Clinical Trials

Vascular Closure With Novel External Compression Device: The LockeT Study

Start date: January 2024
Phase:
Study type: Observational

Single center, retrospective review study comparing Figure of Eight suture to LockeT, enrolling approximately 70 patients.

NCT ID: NCT05822804 Not yet recruiting - Hemostasis Clinical Trials

Safety and Efficacy of the Vascular Closure Device (Tonbridge) in Hemostasis Treatment of Femoral Artery Puncture

Start date: April 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to verify the safety and efficacy of the Vascular Closure Device (Tonbridge) in hemostasis treatment for femoral artery puncture.

NCT ID: NCT05790603 Not yet recruiting - Clinical trials for Percutaneous Coronary Intervention

Effect of Hemostatic Device With Quantitative Pressure on Radial Artery Hemostasis After PCI

PCI
Start date: July 2023
Phase: N/A
Study type: Interventional

The objective of this clinical trial is to compare the hemostatic effect of 2 hemostatic devices with or without quantitative pressure on radial arteries after percutaneous coronary intervention. The main questions aims to answer: - What is the hemostatic effect of the quantitative pressure hemostatic device after percutaneous coronary intervention? - What are the precise hemostasis pressure and hemostasis time of the radial artery after percutaneous coronary intervention? Participants will be randomly assigned to the intervention group (IG) and control group (CG). The IG will use quantitative pressure patent hemostasis, which will be subdivided into three groups: low pressure group, medium pressure group and high pressure group. The CG will use the conventional radial artery hemostatic device without pressure monitoring. The primary outcomes are hemostasis success and incidence of radial artery occlusion. Secondary outcomes include time to hemostasis, rate of bleeding, hematoma, pain, hand swelling, pseudoaneurysm, antebrachial osteofascial compartment syndrome and oxygen saturation of the compressed side thumb.

NCT ID: NCT05511675 Not yet recruiting - Pain Clinical Trials

The Effect of Cold Application on the Hemostasis, Extremity Pain And Terumo Band Usage After Transradial Angiography

Start date: April 15, 2024
Phase: N/A
Study type: Interventional

According to the World Health Organization data, approximately 17.9 million people die every year due to heart disease. 85% of these deaths are due to heart attack and blocked blood vessels. The Turkish Statistical Institute reports that circulatory system diseases took the first place among the causes of death with 38.4%, while ischemic heart diseases constituted 39.7% of these deaths in 2018. Transradial angiography is used for the purpose of scanning and treatment of coronary arteries both in Turkey and in other countries of the world. Aim: After transradial angiography, Terumo (TR) band is used as a common device which is provides pneumatical hemostasis. This study aims to reduce usage time of the TR band, a decrease of hematoma formation and a reduction in the level of extremities pain experienced as a result of transradial angiography, thanks to using the TR band together with cold application.

NCT ID: NCT02071316 Not yet recruiting - Mortality Clinical Trials

The Use of Hexacapron in Upper Gastrointestinal Bleeding

HEXUGI
Start date: April 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to conduct a randomized control trial, double-blind study to compare Hexacapron with standard of care treatment to standard of care alone to evaluate the efficacy of adding effect of Hexacapron to standard therapy by decreasing the episodes of rebleeding and mortality in patient with upper gastrointestinal bleeding.